Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/96392
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
| dc.contributor | Innovation and Technology Development Office | en_US |
| dc.creator | Chan, TH | en_US |
| dc.creator | Wang, CC | en_US |
| dc.date.accessioned | 2022-12-02T01:13:17Z | - |
| dc.date.available | 2022-12-02T01:13:17Z | - |
| dc.identifier.uri | http://hdl.handle.net/10397/96392 | - |
| dc.language.iso | en | en_US |
| dc.title | Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis | en_US |
| dc.type | Patent | en_US |
| dc.description.otherinformation | US10646467; US10646467 B2; US10646467B2; US10,646,467; US10,646,467 B2; 10646467; Appl. No. 16/259620 | en_US |
| dcterms.abstract | Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(−)-EGCG]. Use of PRO-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications. | en_US |
| dcterms.accessRights | open access | en_US |
| dcterms.bibliographicCitation | US Patent 10,646,467 B2. Washington, DC: US Patent and Trademark Office, 2020 | en_US |
| dcterms.issued | 2020-05-12 | - |
| dc.description.country | US | - |
| dc.description.validate | 202211 bcch | en_US |
| dc.description.oa | Version of Record | en_US |
| Appears in Collections: | Patent | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| us10646467b2.pdf | 1.63 MB | Adobe PDF | View/Open |
Page views
83
Last Week
4
4
Last month
Citations as of Nov 30, 2025
Downloads
22
Citations as of Nov 30, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


